Chongqing Kesite Medical Technology Co., Ltd.

I. Company Profile: Chongqing Kesite Medical Technology Co., Ltd. was founded in 2015 and is headquartered in Chongqing. It is a technology-based high-tech enterprise focusing on the respiratory medical field. The company's products are subdivided into multiple series including oxygen inhalation, nebulization, nasal irrigation, and home care. The company has a registered capital of 10 million yuan. Its existing factory land area is approximately 22,000 square meters (approximately 34 mu), and the building area is approximately 17,000 square meters. It is equipped with a series of professional functional areas such as a Class 10,000 sterile laboratory, a Class 100,000 cleanroom workshop, a fully automatic packaging workshop, an ethylene oxide forced resolution room, and a general resolution room. At present, it has passed ISO13485, ISO9001 certification, and GMP factory inspection, and has successively won multiple qualifications and honors such as Technology-based Enterprise, National High-tech Enterprise, Specialized and Sophisticated Enterprise, and Chongqing Intellectual Property Advantage Enterprise. In the field of intellectual property, it has cumulatively obtained 38 authorized patents, 56 registered trademarks, and 10 registered copyrights, with a total of 104 intellectual property achievements; and 35 various qualification certificates. In terms of enterprise strength, Kesite has introduced advanced production equipment, integrated first-class manufacturing processes, built a complete quality management system, and gathered a group of high-quality professional and technical talents. The company currently has more than 100 employees (including branches), with business covering more than 30 provinces and cities across the country, providing high-quality products and services to thousands of medical institutions and tens of millions of users. Its brand "KESITE" adheres to the quality policy of "excellent design, fine manufacturing, professional service, and continuous optimization," always taking customer needs as the guide, building a complete industrial chain system, and continuously creating value for customers. II. Brand: Brand positioning: The brand you can see in hospitals. Brand mission: To relieve the pain of every patient. III. Enterprise Honors: In 2017, passed the "GMP factory" inspection. In 2018, obtained the "National High-tech Enterprise" recognition. In 2019, obtained "ISO13485" certification. In 2020, obtained the "Technology-based Enterprise" certificate. In 2022, obtained the title of "Specialized and Sophisticated Enterprise." In 2023, obtained "ISO9001" certification. In 2025, obtained the title of "Chongqing Intellectual Property Advantage Enterprise." IV. Development History: In 2015, founded in Hechuan District, Chongqing, and entered the Hechuan High-tech Zone Pharmaceutical Industrial Park through investment promotion. In 2016, launched the nebulization series. In 2019, launched the oxygen inhalation series. In 2020, carried out process upgrades and added multiple fully automatic production lines. In 2023, comprehensively developed the online sales field and opened official accounts on multiple platforms such as JD.com, Tmall, Douyin, and Xiaohongshu. In 2024, launched the nasal irrigation series. In 2025, officially completed the "Kesite Medical Factory New Construction Project." The project plans a land area of approximately 20,000 square meters (approximately 30 mu), with a planned total investment of 50 million yuan. In 2025, in the Liaoning Province Inter-provincial Alliance Centralized Procurement Project, won second place in Group A. V. Products: Oxygen inhalation series: disposable oxygen inhalation masks, disposable nasal oxygen tubes (with humidification bottles), disposable nasal oxygen tubes. Nebulization series: adjustable oxygen nebulization inhalers, oxygen nebulization masks, oxygen nebulization inhalers, compressor nebulizers. Nasal irrigation series: nasal cavity irrigators, electric nasal irrigators. Home service series: anti-suffocation first aid devices, braces cleaning agents, household compressor nebulizers. VI. *Recent Developments: At present, the enterprise has successfully obtained the country's first medical device registration certificate for anti-suffocation first aid devices; at the same time, 3 home medical products are in a critical stage of market launch. In the field of centralized procurement of medical consumables: when participating in the "Liaoning 24-Province Alliance" volume-based procurement project in 2025, its oxygen inhalation tube products, with excellent quality and cost advantages, successfully won the bid under the "Group A Rule 1" standard, and simultaneously obtained the qualification for secondary volume allocation and free allocation volume. From the perspective of performance contribution, it is expected to bring more than 100 million yuan in revenue to the enterprise in 2026, and with the increase in procurement product volume, the launch of new home medical products, and the improvement of the channel network, the revenue scale is expected to continue to increase in the coming years; at the long-term planning level, the enterprise aims to achieve an output value of 200 million yuan by 2027, and gradually grow into a benchmark enterprise in the fields of medical emergency and home healthcare with both product competitiveness and market influence.